Harnessing inflammation resolving‐based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID‐19?
Open Access
- 18 June 2020
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 177 (17) , 3898-3904
Abstract
Inflammation is generally accepted as a component of the host defence system and a protective response in the context of infectious diseases. However, altered inflammatory responses can contribute to disease in infected individuals. Many endogenous mediators that drive the resolution of inflammation are now known. Overall, mediators of resolution tend to decrease inflammatory responses and provide normal or greater ability of the host to deal with infection. In the lung, it seems that pro‐resolution molecules, or strategies that promote their increase, tend to suppress inflammation and lung injury and facilitate control of bacterial or viral burden. Here, we argue that the demonstrated anti‐inflammatory, pro‐resolving, anti‐thrombogenic and anti‐microbial effects of such endogenous mediators of resolution may be useful in the treatment of the late stages of the disease in patients with COVID‐19.Keywords
Funding Information
- Ulsan National Institute of Science and Technology (465425/2014‐3)
This publication has 43 references indexed in Scilit:
- THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptorsBritish Journal of Pharmacology, 2019
- THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: EnzymesBritish Journal of Pharmacology, 2019
- Resolvin D4 attenuates the severity of pathological thrombosis in miceBlood, 2019
- Formyl peptide receptor 2 is regulated by RNA mimics and viruses through an IFN‐β‐STAT3‐dependent pathwayThe FASEB Journal, 2018
- Angiotensin-(1-7) Promotes Resolution of Neutrophilic Inflammation in a Model of Antigen-Induced Arthritis in MiceFrontiers in Immunology, 2017
- Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosisCell Death & Differentiation, 2016
- Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammationMucosal Immunology, 2015
- Inflammatory and Innate Immune Responses in Dengue InfectionThe American Journal of Pathology, 2013
- Lethal Dissemination of H5N1 Influenza Virus Is Associated with Dysregulation of Inflammation and Lipoxin Signaling in a Mouse Model of InfectionJournal of Virology, 2010
- A Novel Effect for Annexin 1-Derived Peptide Ac2-26: Reduction of Allergic Inflammation in the RatThe Journal of Pharmacology and Experimental Therapeutics, 2005